These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 1801560)

  • 21. Increased Pentraxin 3 Levels Correlate With IVIG Responsiveness and Coronary Artery Aneurysm Formation in Kawasaki Disease.
    Kitoh T; Ohara T; Muto T; Okumura A; Baba R; Koizumi Y; Yamagishi Y; Mikamo H; Daigo K; Hamakubo T
    Front Immunol; 2021; 12():624802. PubMed ID: 33912155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Therapeutic effectiveness of intravenous immunoglobulin at 1 g/kg and 2 g/kg on Kawasaki disease: a comparative and follow-up study].
    Qin LJ; Wang HW; Hu XF; Liu QJ; Shi H; Wei YX; Chen QJ; Cheng PX
    Zhonghua Er Ke Za Zhi; 2006 Dec; 44(12):891-5. PubMed ID: 17254453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic impact of vascular leakage in acute Kawasaki disease.
    Terai M; Honda T; Yasukawa K; Higashi K; Hamada H; Kohno Y
    Circulation; 2003 Jul; 108(3):325-30. PubMed ID: 12835221
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Study on coronary artery lesions in patients with Kawasaki disease: recent 9 years' experience].
    Wu JR; Hwang KP; Tu JG; Dai ZK; Huang TY
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1993 Jan; 9(1):27-38. PubMed ID: 7682261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical analysis of 942 cases of Kawasaki disease].
    Zhang W; Li Q; Zhao XD; Tang XM; Wang XG; Wang M; Wu DQ; Ou Q; Yang XQ
    Zhonghua Er Ke Za Zhi; 2006 May; 44(5):324-8. PubMed ID: 16780705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coronary risk factors in acute Kawasaki disease: correlation of serum immunoglobulin levels with coronary complications.
    Sawaji Y; Haneda N; Yamaguchi S; Kajino Y; Kishida K; Seto S; Konishi N; Waki K; Baba K; Arisawa K; Kamiya T; Mori C
    Acta Paediatr Jpn; 1998 Jun; 40(3):218-25. PubMed ID: 9695293
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-dose intravenous gamma-globulin therapy in Kawasaki disease.
    Hwang BT; Lin CY; Hsieh KS; Tsuei DH; Meng CC
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1989; 30(1):15-22. PubMed ID: 2484055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of FcRs on monocytes among Kawasaki disease patients with coronary artery lesions.
    Xia Y; Tian X; Li Q; Wang G; Li C; Yang J
    Int Immunopharmacol; 2017 Apr; 45():1-5. PubMed ID: 28147297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of Kawasaki disease in the British Isles.
    Dhillon R; Newton L; Rudd PT; Hall SM
    Arch Dis Child; 1993 Dec; 69(6):631-6; discussion 637-8. PubMed ID: 8285773
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Kawasaki disease in children--9 years experience].
    Kowalczyk M; Kawalec W; Daszkowska-York J; Turska-Kmieć A; Brzezińska-Rajszys G; Sobielarska D; Ziółkowska L; Kościesza A; Jagiełłowicz D; Mirecka-Rola A
    Med Wieku Rozwoj; 2005; 9(2):179-93. PubMed ID: 16085959
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kawasaki disease. Kawasaki disease?
    Moss KW
    Alaska Med; 2000; 42(2):30-6. PubMed ID: 10916855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prevention of coronary artery aneurysm in Kawasaki disease: a meta-analysis on the efficacy of aspirin and immunoglobulin treatment.
    Durongpisitkul K; Gururaj VJ; Park JM; Martin CF
    Pediatrics; 1995 Dec; 96(6):1057-61. PubMed ID: 7491221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of coronary artery lesions on the initial echocardiogram in Kawasaki syndrome.
    Baer AZ; Rubin LG; Shapiro CA; Sood SK; Rajan S; Shapir Y; Romano A; Bierman FZ
    Arch Pediatr Adolesc Med; 2006 Jul; 160(7):686-90. PubMed ID: 16818833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Iv gamma globulin treatment of Kawasaki disease in Japan: results of a nationwide survey.
    Yanagawa H; Yashiro M; Nakamura Y; Sakata K; Kawasaki T
    Acta Paediatr; 1995 Jul; 84(7):765-8. PubMed ID: 7549294
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictive risk factors for coronary artery abnormalities in Kawasaki disease.
    Kim T; Choi W; Woo CW; Choi B; Lee J; Lee K; Son C; Lee J
    Eur J Pediatr; 2007 May; 166(5):421-5. PubMed ID: 17033807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple giant succular and fusiform right and left coronary artery aneurysms after early and adequate treatment of atypical kawasaki disease with unusual presentation.
    Behjati-Ardakani M; Ferdosian F
    Acta Med Iran; 2014; 52(6):490-2. PubMed ID: 25130161
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neutropenia in the acute phase of Kawasaki disease and prevention of coronary artery aneurysm.
    Onouchi Z; Hamaoka K; Ozawa S; Sakata K; Kiyosawa N; Ito H
    Pediatr Int; 2009 Aug; 51(4):448-52. PubMed ID: 19674356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preventing Long-Term Cardiac Damage in Pediatric Patients With Kawasaki Disease.
    Williams K
    J Pediatr Health Care; 2017; 31(2):196-202. PubMed ID: 27592169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gamma globulin re-treatment in Kawasaki disease.
    Sundel RP; Burns JC; Baker A; Beiser AS; Newburger JW
    J Pediatr; 1993 Oct; 123(4):657-9. PubMed ID: 8410524
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extracoronary echocardiographic findings as predictors of coronary artery lesions in the initial phase of Kawasaki disease.
    Lega JC; Bozio A; Cimaz R; Veyrier M; Floret D; Ducreux C; Reix P; Di Filippo S
    Arch Dis Child; 2013 Feb; 98(2):97-102. PubMed ID: 23235890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.